Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SARA: Safety of Progesterone Vaginal Ring in ART
NCT03565211Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jul 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of progesterone in infertility, sponsored by Ferring Pharmaceuticals. Primary endpoint: Cumulative Rate of Spontaneous Abortions Occurring on or Before 12 Weeks Post-oocyte Retrieval. Started Jul 2018; status: completed.
02
Drugs
progesterone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03565211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03565211.